Motiva Korea Achieves Two Consecutive Years of Growth, Strengthens Market Competitiveness

Motiva Korea announced on the 29th that it has continued to strengthen its competitiveness in the domestic breast implant market, maintaining growth in performance over the past two years.

Motiva Korea has been gradually expanding its presence in the breast implant market, which has traditionally been led by global conglomerates, by leveraging effective sales and marketing strategies. Last year, Motiva Korea recorded sales of 25.1 billion won, a 21.6% increase compared to the previous year, while EBITDA rose from 3.8 billion won to 6.8 billion won during the same period. The company also reported that its third-quarter results this year have clearly surpassed those of the same period last year.

The improvement in Motiva Korea's performance is attributed to the success of its sales and marketing strategies, which are based on strengthening the competitiveness of its products and services. Notably, last year, the U.S. Food and Drug Administration (FDA) approved Motiva's "SmoothSilk® Ergonomix®" product for use in breast augmentation and revision surgeries. This confirmed that the product meets global standards for quality and safety.

Going forward, Motiva Korea plans to further strengthen its market competitiveness by pursuing continued external growth and internal stability, focusing on its core markets.

Im Sinyeong, CEO of Motiva Korea, stated, "We will continue our efforts to ensure that Motiva products remain a safe and reliable choice for customers worldwide," adding, "We will also focus on product development and quality improvement to further solidify our market position."

Meanwhile, Motiva Korea is an affiliate of Incredible Buzz and has been actively developing its distribution business since obtaining domestic approval for breast implants in 2016. The company continues to grow by creating synergy in product sales, leveraging a stable network of domestic hospitals and clinics.